Delete archive
Browse files- archive/COVID/ym005/README.md +0 -43
- archive/COVID/ym005/YM_005.csv +0 -3
- archive/COVID/ym1068/README.md +0 -50
- archive/COVID/ym1068/YM_1068.csv +0 -3
- archive/COVID/ym549/README.md +0 -45
- archive/COVID/ym549/YM_549.csv +0 -3
- archive/HER2/ym989/README.md +0 -43
- archive/HER2/ym989/YM_989.csv +0 -3
- archive/HER2/ym990/README.md +0 -43
- archive/HER2/ym990/YM_990.csv +0 -3
- archive/PD1/ym852/README.md +0 -43
- archive/PD1/ym852/YM_852.csv +0 -3
- archive/PD1/ym985/README.md +0 -43
- archive/PD1/ym985/YM_985.csv +0 -3
- archive/TIGIT/ym693/README.md +0 -41
- archive/TIGIT/ym693/YM_693.csv +0 -3
- archive/TIGIT/ym988/README.md +0 -44
- archive/TIGIT/ym988/YM_988.csv +0 -3
archive/COVID/ym005/README.md
DELETED
|
@@ -1,43 +0,0 @@
|
|
| 1 |
-
# Covid mutagenesis dataset (YM_005)
|
| 2 |
-
|
| 3 |
-
## Overview
|
| 4 |
-
|
| 5 |
-
YM_005 is a Covid receptor-binding domain (RBD) single-site mutagenesis (SSM) library against a panel of 33 ScFvs.
|
| 6 |
-
|
| 7 |
-
## Experimental details
|
| 8 |
-
|
| 9 |
-
We studied the effects of a panel of ScFvs against COVID RBD. In this dataset, our panel of ScFvs are tested in 2 orientations: LH for light-heavy chains and HL heavy-light chains. We explore the local landscape of the RBD in tandem with Covid for epitope mapping by mutating each position. We include a control of ACE2, as the protein of most therapeutic antibodies disrupt.
|
| 10 |
-
|
| 11 |
-
This dataset includes 62 unique scFvs and 2431 unique RBD sequences.
|
| 12 |
-
|
| 13 |
-
A more extensive methods section can be found in our publication [here](https://academic.oup.com/abt/article/5/2/130/6584706#372391532).
|
| 14 |
-
|
| 15 |
-
## Dataset schema
|
| 16 |
-
|
| 17 |
-
The dataset will contain the following columns:
|
| 18 |
-
|
| 19 |
-
- `mata_description`: Description of the scfvs; HL/LH indicate orientation of light/heavy or heavy/light
|
| 20 |
-
- `mata_sequence`: Scfv sequences
|
| 21 |
-
- `matalpha_description`: Description of the RBD mutation
|
| 22 |
-
- `matalpha_sequence`: Sequence of the covid binding protein
|
| 23 |
-
- `alphaseq_affinity`: Log10 Kd affinity score between the pair of sequences
|
| 24 |
-
- `alphaseq_affinity_lower_bound`: Lower bound of affinity
|
| 25 |
-
- `alphaseq_affinity_upper_bound`: Upper bound of affinity
|
| 26 |
-
|
| 27 |
-
## Misc dataset details
|
| 28 |
-
|
| 29 |
-
We define the following binders:
|
| 30 |
-
|
| 31 |
-
### A-library: (scFvs)
|
| 32 |
-
- `ACE2_Full`:
|
| 33 |
-
- `CR3022_scFv_LH_Mod`:
|
| 34 |
-
- `MERS_VHH55`:
|
| 35 |
-
- `SARS_VHH72`:
|
| 36 |
-
- `m396_scFv_LH_Mod`:
|
| 37 |
-
|
| 38 |
-
### Alpha-library:
|
| 39 |
-
- Any `matalpha_description` that contains the term "WT" can be assumed as a replicate of the WT target. Other sequences will be indicated by their original residue, position of mutation, and mutated residue (i.e. S23A is Ser -> Ala mutation in position 23).
|
| 40 |
-
|
| 41 |
-
## Citation
|
| 42 |
-
Please cite
|
| 43 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
archive/COVID/ym005/YM_005.csv
DELETED
|
@@ -1,3 +0,0 @@
|
|
| 1 |
-
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:c6729ce3cd038b35a4c8849a91234b2b05f01d51cadda0defc91c86d5e0f7f08
|
| 3 |
-
size 80151625
|
|
|
|
|
|
|
|
|
|
|
|
archive/COVID/ym1068/README.md
DELETED
|
@@ -1,50 +0,0 @@
|
|
| 1 |
-
# Covid antibody optimization designs (YM_1068)
|
| 2 |
-
|
| 3 |
-
## Overview
|
| 4 |
-
|
| 5 |
-
YM_1068 are VHH72 designs against SARS CoV-2 RBD. We explored several model hypothesis: (i) Does pre-training aid predicitivity and (ii) does the featurization of the input sequences matter. To test pretraining, we refer to `mata_descriptions` with the term \textbf{warm} to include pretraining, and \textbf{cold} to start from a randomly initialized seed. For featurization, we explored \textbf{label-encoded} sequences with a one-hot-encoder of amino acid identities, versus an \textbf{ESM}-featurized embedding to represent each sequence in the PPI.
|
| 6 |
-
|
| 7 |
-
## Experimental details
|
| 8 |
-
|
| 9 |
-
We studied the efficacy of generating binders with different model hyperparameters. This dataset includes 36862 unique VHHs and 8 unique RBD sequences.
|
| 10 |
-
|
| 11 |
-
A more extensive methods section can be found in our publication [here](https://pmc.ncbi.nlm.nih.gov/articles/PMC12296056/).
|
| 12 |
-
|
| 13 |
-
## Dataset schema
|
| 14 |
-
|
| 15 |
-
The dataset will contain the following columns:
|
| 16 |
-
|
| 17 |
-
- `mata_description`: Description of the binder designs; contains warm/cold or label-encoded/ESM information. WT indicated as "WT"
|
| 18 |
-
- `mata_sequence`: VHH sequences
|
| 19 |
-
- `matalpha_description`: SARS-Cov 2 RBD proteins
|
| 20 |
-
- `matalpha_sequence`: Sequence of the covid binding protein
|
| 21 |
-
- `alphaseq_affinity`: Log10 Kd affinity score between the pair of sequences
|
| 22 |
-
- `alphaseq_affinity_lower_bound`: Lower bound of affinity
|
| 23 |
-
- `alphaseq_affinity_upper_bound`: Upper bound of affinity
|
| 24 |
-
|
| 25 |
-
## Misc dataset details
|
| 26 |
-
|
| 27 |
-
We define the following binders:
|
| 28 |
-
|
| 29 |
-
### A-library: (scFvs)
|
| 30 |
-
There are several terms you can filter by:
|
| 31 |
-
|
| 32 |
-
- `VHH_WT_<i>`: These are WT replicates.
|
| 33 |
-
- `VHH_label_encoded_cold`: Label encoded sequences with no pretraining
|
| 34 |
-
- `VHH_label_encoded_warm`: Label encoded sequences with pretraining
|
| 35 |
-
- `VHH_esm_cold`: ESM featurized sequences with no pretraining
|
| 36 |
-
- `VHH_esm_warm`: ESM featurized sequences with pretraining
|
| 37 |
-
|
| 38 |
-
### Alpha-library:
|
| 39 |
-
- `SARS-CoV2_RBD_(6LZG)`
|
| 40 |
-
- `WIV1`
|
| 41 |
-
- `LYRa11`
|
| 42 |
-
- `MERS_RBD`
|
| 43 |
-
- `OMICRON_BA2_TStarr_Seq&Trunc`
|
| 44 |
-
- `SARS-COV-2_GAMMA_RBD_LLNL_Trunc`
|
| 45 |
-
- `SARS-CoV-2_Delta_RBD_L452R_T478K`
|
| 46 |
-
- `SARS-CoV1_RBD_(6LZG_Mimic)`
|
| 47 |
-
|
| 48 |
-
## Citation
|
| 49 |
-
Please cite
|
| 50 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
archive/COVID/ym1068/YM_1068.csv
DELETED
|
@@ -1,3 +0,0 @@
|
|
| 1 |
-
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:80c4c446476014a95feaa080c791017a12298655b85de32d85edae107548afa8
|
| 3 |
-
size 128842385
|
|
|
|
|
|
|
|
|
|
|
|
archive/COVID/ym549/README.md
DELETED
|
@@ -1,45 +0,0 @@
|
|
| 1 |
-
# VHH72 COVID designs (YM-549)
|
| 2 |
-
|
| 3 |
-
## Overview
|
| 4 |
-
|
| 5 |
-
YM_549 are VHH72 designs against SARS CoV-2 RBD. We wanted to perturb the local landscape of VHH72, so we performed mutagenesis to observe the sensitivity of VHH-72 to different RBD targets. This dataset is great to study the local sensitivity of mutations relative to parent "WT" VHH72.
|
| 6 |
-
|
| 7 |
-
## Experimental details
|
| 8 |
-
|
| 9 |
-
This dataset includes 29765 unique VHHs and 8 unique RBD sequences. The alpha-library is the same as YM_1068.
|
| 10 |
-
|
| 11 |
-
## Dataset schema
|
| 12 |
-
|
| 13 |
-
The dataset will contain the following columns:
|
| 14 |
-
|
| 15 |
-
- `mata_description`: Candidate labels
|
| 16 |
-
- `mata_sequence`: VHH sequences
|
| 17 |
-
- `matalpha_description`: SARS-Cov 2 RBD proteins
|
| 18 |
-
- `matalpha_sequence`: Sequence of the covid binding protein
|
| 19 |
-
- `alphaseq_affinity`: Log10 Kd affinity score between the pair of sequences
|
| 20 |
-
- `alphaseq_affinity_lower_bound`: Lower bound of affinity
|
| 21 |
-
- `alphaseq_affinity_upper_bound`: Upper bound of affinity
|
| 22 |
-
|
| 23 |
-
## Misc dataset details
|
| 24 |
-
|
| 25 |
-
We define the following binders:
|
| 26 |
-
|
| 27 |
-
### A-library: (scFvs)
|
| 28 |
-
There are several terms you can filter by:
|
| 29 |
-
|
| 30 |
-
- `wt_<i>`: These are WT replicates.
|
| 31 |
-
- `candidate_`: Various mutations of VHH-72
|
| 32 |
-
|
| 33 |
-
### Alpha-library:
|
| 34 |
-
- `SARS-CoV2_RBD_(6LZG)`
|
| 35 |
-
- `WIV1`
|
| 36 |
-
- `LYRa11`
|
| 37 |
-
- `MERS_RBD`
|
| 38 |
-
- `OMICRON_BA2_TStarr_Seq&Trunc`
|
| 39 |
-
- `SARS-COV-2_GAMMA_RBD_LLNL_Trunc`
|
| 40 |
-
- `SARS-CoV-2_Delta_RBD_L452R_T478K`
|
| 41 |
-
- `SARS-CoV1_RBD_(6LZG_Mimic)`
|
| 42 |
-
|
| 43 |
-
## Citation
|
| 44 |
-
Please cite
|
| 45 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
archive/COVID/ym549/YM_549.csv
DELETED
|
@@ -1,3 +0,0 @@
|
|
| 1 |
-
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:549e9e645e6a089dc2b2ef889fcd3b317e68ecf8d8e399ccbe328801f157c767
|
| 3 |
-
size 99893870
|
|
|
|
|
|
|
|
|
|
|
|
archive/HER2/ym989/README.md
DELETED
|
@@ -1,43 +0,0 @@
|
|
| 1 |
-
# Trastuzumab CDR designs (YM_989)
|
| 2 |
-
|
| 3 |
-
## Overview
|
| 4 |
-
|
| 5 |
-
YM_989 are Trastuzumab designs against HER2. We explored several model hypothesis: (i) Does pre-training aid predicitivity and (ii) does the featurization of the input sequences matter. To test pretraining, we refer to `mata_descriptions` with the term \textbf{warm} to include pretraining, and \textbf{cold} to start from a randomly initialized seed. For featurization, we explored \textbf{label-encoded} sequences with a one-hot-encoder of amino acid identities, versus an \textbf{ESM}-featurized embedding to represent each sequence in the PPI.
|
| 6 |
-
|
| 7 |
-
## Experimental details
|
| 8 |
-
|
| 9 |
-
We studied the efficacy of generating binders with different model hyperparameters. This dataset includes 20828 unique VHHs and 1 unique sequences. All designs are limited to the CDRs of the proteins of interest
|
| 10 |
-
|
| 11 |
-
A more extensive methods section can be found in our publication [here](https://pmc.ncbi.nlm.nih.gov/articles/PMC12296056/).
|
| 12 |
-
|
| 13 |
-
## Dataset schema
|
| 14 |
-
|
| 15 |
-
The dataset will contain the following columns:
|
| 16 |
-
|
| 17 |
-
- `mata_description`: Description of the binder designs; contains warm/cold or label-encoded/ESM information. WT indicated as "WT"
|
| 18 |
-
- `mata_sequence`: scFv sequences
|
| 19 |
-
- `matalpha_description`: HER2 protein
|
| 20 |
-
- `matalpha_sequence`: HER2 sequence
|
| 21 |
-
- `alphaseq_affinity`: Log10 Kd affinity score between the pair of sequences
|
| 22 |
-
- `alphaseq_affinity_lower_bound`: Lower bound of affinity
|
| 23 |
-
- `alphaseq_affinity_upper_bound`: Upper bound of affinity
|
| 24 |
-
|
| 25 |
-
## Misc dataset details
|
| 26 |
-
|
| 27 |
-
We define the following binders:
|
| 28 |
-
|
| 29 |
-
### A-library: (scFvs)
|
| 30 |
-
There are several terms you can filter by:
|
| 31 |
-
|
| 32 |
-
- `TrastuzumabCDR_WT_<i>`: These are WT replicates.
|
| 33 |
-
- `TrastuzumabCDR_label_encoded_cold`: Label encoded sequences with no pretraining
|
| 34 |
-
- `TrastuzumabCDR_label_encoded_warm`: Label encoded sequences with pretraining
|
| 35 |
-
- `TrastuzumabCDR_esm_cold`: ESM featurized sequences with no pretraining
|
| 36 |
-
- `TrastuzumabCDR_esm_warm`: ESM featurized sequences with pretraining
|
| 37 |
-
|
| 38 |
-
### Alpha-library:
|
| 39 |
-
There is only 1 target of interest.
|
| 40 |
-
|
| 41 |
-
## Citation
|
| 42 |
-
Please cite
|
| 43 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
archive/HER2/ym989/YM_989.csv
DELETED
|
@@ -1,3 +0,0 @@
|
|
| 1 |
-
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:76c0b0c751707ba5c6376323940d7736e0c1d5ededa63727b78472e0d53c3461
|
| 3 |
-
size 11312796
|
|
|
|
|
|
|
|
|
|
|
|
archive/HER2/ym990/README.md
DELETED
|
@@ -1,43 +0,0 @@
|
|
| 1 |
-
# Trastuzumab CDR + framework designs (YM_989)
|
| 2 |
-
|
| 3 |
-
## Overview
|
| 4 |
-
|
| 5 |
-
YM_989 are Trastuzumab designs against HER2. We explored several model hypothesis: (i) Does pre-training aid predicitivity and (ii) does the featurization of the input sequences matter. To test pretraining, we refer to `mata_descriptions` with the term \textbf{warm} to include pretraining, and \textbf{cold} to start from a randomly initialized seed. For featurization, we explored \textbf{label-encoded} sequences with a one-hot-encoder of amino acid identities, versus an \textbf{ESM}-featurized embedding to represent each sequence in the PPI.
|
| 6 |
-
|
| 7 |
-
## Experimental details
|
| 8 |
-
|
| 9 |
-
We studied the efficacy of generating binders with different model hyperparameters. This dataset includes 20828 unique VHHs and 1 unique sequences. In this experiment, we enable designs to span a window that encompasses the frameworks and CDR regions.
|
| 10 |
-
|
| 11 |
-
A more extensive methods section can be found in our publication [here](https://pmc.ncbi.nlm.nih.gov/articles/PMC12296056/).
|
| 12 |
-
|
| 13 |
-
## Dataset schema
|
| 14 |
-
|
| 15 |
-
The dataset will contain the following columns:
|
| 16 |
-
|
| 17 |
-
- `mata_description`: Description of the binder designs; contains warm/cold or label-encoded/ESM information. WT indicated as "WT"
|
| 18 |
-
- `mata_sequence`: scFv sequences
|
| 19 |
-
- `matalpha_description`: HER2 protein
|
| 20 |
-
- `matalpha_sequence`: HER2 sequence
|
| 21 |
-
- `alphaseq_affinity`: Log10 Kd affinity score between the pair of sequences
|
| 22 |
-
- `alphaseq_affinity_lower_bound`: Lower bound of affinity
|
| 23 |
-
- `alphaseq_affinity_upper_bound`: Upper bound of affinity
|
| 24 |
-
|
| 25 |
-
## Misc dataset details
|
| 26 |
-
|
| 27 |
-
We define the following binders:
|
| 28 |
-
|
| 29 |
-
### A-library: (scFvs)
|
| 30 |
-
There are several terms you can filter by:
|
| 31 |
-
|
| 32 |
-
- `TrastuzumabCDR_WT_<i>`: These are WT replicates.
|
| 33 |
-
- `TrastuzumabCDR_label_encoded_cold`: Label encoded sequences with no pretraining
|
| 34 |
-
- `TrastuzumabCDR_label_encoded_warm`: Label encoded sequences with pretraining
|
| 35 |
-
- `TrastuzumabCDR_esm_cold`: ESM featurized sequences with no pretraining
|
| 36 |
-
- `TrastuzumabCDR_esm_warm`: ESM featurized sequences with pretraining
|
| 37 |
-
|
| 38 |
-
### Alpha-library:
|
| 39 |
-
There is only 1 target of interest.
|
| 40 |
-
|
| 41 |
-
## Citation
|
| 42 |
-
Please cite
|
| 43 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
archive/HER2/ym990/YM_990.csv
DELETED
|
@@ -1,3 +0,0 @@
|
|
| 1 |
-
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:1211f21ee40759bcc9a049c22a15c0d57152e66b6ebfb22a200fd38ecf52e25a
|
| 3 |
-
size 17966062
|
|
|
|
|
|
|
|
|
|
|
|
archive/PD1/ym852/README.md
DELETED
|
@@ -1,43 +0,0 @@
|
|
| 1 |
-
# {DATASET}
|
| 2 |
-
|
| 3 |
-
## Overview
|
| 4 |
-
|
| 5 |
-
YM_852 are Pembrolizumab mutations against its native target; we introduce mutations that include deletions, insertions, double and single mutations to quantify the sensitivity of the local landscape in engaging the native target.
|
| 6 |
-
|
| 7 |
-
## Experimental details
|
| 8 |
-
|
| 9 |
-
This dataset includes 29883 unique scFvs and 1 unique native target sequence. A more extensive methods section can be found in our publication [here](https://pmc.ncbi.nlm.nih.gov/articles/PMC12296056/).
|
| 10 |
-
|
| 11 |
-
## Dataset schema
|
| 12 |
-
|
| 13 |
-
The dataset will contain the following columns:
|
| 14 |
-
|
| 15 |
-
- `mata_description`: Description of the binder designs; contains warm/cold or label-encoded/ESM information. WT indicated as "WT_"
|
| 16 |
-
- `mata_sequence`: VHH sequences
|
| 17 |
-
- `matalpha_description`: SARS-Cov 2 RBD proteins
|
| 18 |
-
- `matalpha_sequence`: Sequence of the covid binding protein
|
| 19 |
-
- `alphaseq_affinity`: Log10 Kd affinity score between the pair of sequences
|
| 20 |
-
- `alphaseq_affinity_lower_bound`: Lower bound of affinity
|
| 21 |
-
- `alphaseq_affinity_upper_bound`: Upper bound of affinity
|
| 22 |
-
|
| 23 |
-
## Misc dataset details
|
| 24 |
-
|
| 25 |
-
We define the following binders:
|
| 26 |
-
|
| 27 |
-
### A-library: (scFvs)
|
| 28 |
-
There are several terms you can filter by:
|
| 29 |
-
|
| 30 |
-
- `WT_<i>`: These are WT replicates.
|
| 31 |
-
- `del_<i>`: A deletion from the WT
|
| 32 |
-
- `ins_<i>`: An insertion from WT
|
| 33 |
-
- `pair_<i>`: A double mutation (2 residues mutated from WT)
|
| 34 |
-
- `single_<i>`: A single mutation
|
| 35 |
-
|
| 36 |
-
To get the mutations of interest relative to the parent, we recommend an alignment to the WT sequence.
|
| 37 |
-
|
| 38 |
-
### Alpha-library:
|
| 39 |
-
There is only 1 sequence, which is the native target.
|
| 40 |
-
|
| 41 |
-
## Citation
|
| 42 |
-
Please cite
|
| 43 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
archive/PD1/ym852/YM_852.csv
DELETED
|
@@ -1,3 +0,0 @@
|
|
| 1 |
-
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:34b186fe5d14dc6284e109c919e27d20ef3245e6e7bdf990f99eb559dce6a590
|
| 3 |
-
size 13669983
|
|
|
|
|
|
|
|
|
|
|
|
archive/PD1/ym985/README.md
DELETED
|
@@ -1,43 +0,0 @@
|
|
| 1 |
-
# Pembrolizumab Designs (YM_985)
|
| 2 |
-
|
| 3 |
-
## Overview
|
| 4 |
-
|
| 5 |
-
YM_985 includes Alphabind designs against PD-1. We explored several model hypothesis: (i) Does pre-training aid predicitivity and (ii) does the featurization of the input sequences matter. To test pretraining, we refer to `mata_descriptions` with the term \textbf{warm} to include pretraining, and \textbf{cold} to start from a randomly initialized seed. For featurization, we explored \textbf{label-encoded} sequences with a one-hot-encoder of amino acid identities, versus an \textbf{ESM}-featurized embedding to represent each sequence in the PPI.
|
| 6 |
-
|
| 7 |
-
## Experimental details
|
| 8 |
-
|
| 9 |
-
We studied the efficacy of generating binders with different model hyperparameters. This dataset includes 34890 unique VHHs and 1 unique RBD sequences.
|
| 10 |
-
|
| 11 |
-
A more extensive methods section can be found in our publication [here](https://pmc.ncbi.nlm.nih.gov/articles/PMC12296056/).
|
| 12 |
-
|
| 13 |
-
## Dataset schema
|
| 14 |
-
|
| 15 |
-
The dataset will contain the following columns:
|
| 16 |
-
|
| 17 |
-
- `mata_description`: Description of the binder designs; contains warm/cold or label-encoded/ESM information. WT indicated as "WT"
|
| 18 |
-
- `mata_sequence`: scFv sequences
|
| 19 |
-
- `matalpha_description`: The target protein of interest
|
| 20 |
-
- `matalpha_sequence`: Target sequence (only 1)
|
| 21 |
-
- `alphaseq_affinity`: Log10 Kd affinity score between the pair of sequences
|
| 22 |
-
- `alphaseq_affinity_lower_bound`: Lower bound of affinity
|
| 23 |
-
- `alphaseq_affinity_upper_bound`: Upper bound of affinity
|
| 24 |
-
|
| 25 |
-
## Misc dataset details
|
| 26 |
-
|
| 27 |
-
We define the following binders:
|
| 28 |
-
|
| 29 |
-
### A-library: (scFvs)
|
| 30 |
-
There are several terms you can filter by:
|
| 31 |
-
|
| 32 |
-
- `Pembro144_WT_<i>`: These are WT replicates.
|
| 33 |
-
- `Pembro144_label_encoded_cold`: Label encoded sequences with no pretraining
|
| 34 |
-
- `Pembro144_label_encoded_warm`: Label encoded sequences with pretraining
|
| 35 |
-
- `Pembro144_esm_cold`: ESM featurized sequences with no pretraining
|
| 36 |
-
- `Pembro144_esm_warm`: ESM featurized sequences with pretraining
|
| 37 |
-
|
| 38 |
-
### Alpha-library:
|
| 39 |
-
There is only 1 target
|
| 40 |
-
|
| 41 |
-
## Citation
|
| 42 |
-
Please cite
|
| 43 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
archive/PD1/ym985/YM_985.csv
DELETED
|
@@ -1,3 +0,0 @@
|
|
| 1 |
-
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:d5f846ba0fac92a4b0b6c35cbcee521f7623c9479b44d6c0d47c481092678d52
|
| 3 |
-
size 17767857
|
|
|
|
|
|
|
|
|
|
|
|
archive/TIGIT/ym693/README.md
DELETED
|
@@ -1,41 +0,0 @@
|
|
| 1 |
-
# anti-TIGIT designs (YM_693)
|
| 2 |
-
|
| 3 |
-
## Overview
|
| 4 |
-
|
| 5 |
-
YM_693 is a dataset of anti-TIGIT designs against the TIGIT target. This dataset contains only 2 targets, but they are species homologs of human and mouse. The designs offer a few mutations to study the local interaction between and TIGIT. This is a dataset to explore relative affinities to the parent for antibody optimization.
|
| 6 |
-
|
| 7 |
-
## Experimental details
|
| 8 |
-
|
| 9 |
-
We studied the efficacy of generating binders with different model hyperparameters. This dataset includes 26726 unique scFvs and 2 unique target sequences.
|
| 10 |
-
|
| 11 |
-
A more extensive methods section can be found in our publication [here](https://pmc.ncbi.nlm.nih.gov/articles/PMC12296056/).
|
| 12 |
-
|
| 13 |
-
## Dataset schema
|
| 14 |
-
|
| 15 |
-
The dataset will contain the following columns:
|
| 16 |
-
|
| 17 |
-
- `mata_description`: Candidate labels
|
| 18 |
-
- `mata_sequence`: scFv sequences
|
| 19 |
-
- `matalpha_description`: TIGIT proteins
|
| 20 |
-
- `matalpha_sequence`: Sequence of the TIGIT homolog
|
| 21 |
-
- `alphaseq_affinity`: Log10 Kd affinity score between the pair of sequences
|
| 22 |
-
- `alphaseq_affinity_lower_bound`: Lower bound of affinity
|
| 23 |
-
- `alphaseq_affinity_upper_bound`: Upper bound of affinity
|
| 24 |
-
|
| 25 |
-
## Misc dataset details
|
| 26 |
-
|
| 27 |
-
We define the following binders:
|
| 28 |
-
|
| 29 |
-
### A-library: (scFvs)
|
| 30 |
-
There are several terms you can filter by:
|
| 31 |
-
|
| 32 |
-
- `wt_<i>`: These are WT replicates.
|
| 33 |
-
- `candidate_`: Various mutations of Pembrolizumab
|
| 34 |
-
|
| 35 |
-
### Alpha-library:
|
| 36 |
-
- `TIGIT_22-137_POI-AGA2`: Human TIGIT
|
| 37 |
-
- `TIGIT_Mouse`: Mouse TIGIT
|
| 38 |
-
|
| 39 |
-
## Citation
|
| 40 |
-
Please cite
|
| 41 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
archive/TIGIT/ym693/YM_693.csv
DELETED
|
@@ -1,3 +0,0 @@
|
|
| 1 |
-
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:dba00e7fb0a90e825590966a3693ff86814eaaa7f251f707efbb8612a3c4fa1e
|
| 3 |
-
size 23452956
|
|
|
|
|
|
|
|
|
|
|
|
archive/TIGIT/ym988/README.md
DELETED
|
@@ -1,44 +0,0 @@
|
|
| 1 |
-
# anti-TIGIT designs (YM_1068)
|
| 2 |
-
|
| 3 |
-
## Overview
|
| 4 |
-
|
| 5 |
-
YM_988 includes ABC001 against 2 TIGIT homologs. We explored several model hypothesis: (i) Does pre-training aid predicitivity and (ii) does the featurization of the input sequences matter. To test pretraining, we refer to `mata_descriptions` with the term \textbf{warm} to include pretraining, and \textbf{cold} to start from a randomly initialized seed. For featurization, we explored \textbf{label-encoded} sequences with a one-hot-encoder of amino acid identities, versus an \textbf{ESM}-featurized embedding to represent each sequence in the PPI. Optimization was performed on the human ortholog.
|
| 6 |
-
|
| 7 |
-
## Experimental details
|
| 8 |
-
|
| 9 |
-
We studied the efficacy of generating binders with different model hyperparameters. This dataset includes 35929 unique scFvs and 2 unique TIGIT homologs sequences.
|
| 10 |
-
|
| 11 |
-
A more extensive methods section can be found in our publication [here](https://pmc.ncbi.nlm.nih.gov/articles/PMC12296056/).
|
| 12 |
-
|
| 13 |
-
## Dataset schema
|
| 14 |
-
|
| 15 |
-
The dataset will contain the following columns:
|
| 16 |
-
|
| 17 |
-
- `mata_description`: Description of the binder designs; contains warm/cold or label-encoded/ESM information. WT indicated as "WT"
|
| 18 |
-
- `mata_sequence`: svFv sequences
|
| 19 |
-
- `matalpha_description`: TIGIT homologs
|
| 20 |
-
- `matalpha_sequence`: Sequence of the TIGIT protein
|
| 21 |
-
- `alphaseq_affinity`: Log10 Kd affinity score between the pair of sequences
|
| 22 |
-
- `alphaseq_affinity_lower_bound`: Lower bound of affinity
|
| 23 |
-
- `alphaseq_affinity_upper_bound`: Upper bound of affinity
|
| 24 |
-
|
| 25 |
-
## Misc dataset details
|
| 26 |
-
|
| 27 |
-
We define the following binders:
|
| 28 |
-
|
| 29 |
-
### A-library: (scFvs)
|
| 30 |
-
There are several terms you can filter by:
|
| 31 |
-
|
| 32 |
-
- `ABC001_WT_<i>`: These are WT replicates.
|
| 33 |
-
- `ABC001_label_encoded_cold`: Label encoded sequences with no pretraining
|
| 34 |
-
- `ABC001_label_encoded_warm`: Label encoded sequences with pretraining
|
| 35 |
-
- `ABC001_esm_cold`: ESM featurized sequences with no pretraining
|
| 36 |
-
- `ABC001_esm_warm`: ESM featurized sequences with pretraining
|
| 37 |
-
|
| 38 |
-
### Alpha-library:
|
| 39 |
-
- `TIGIT_22-137_POI-AGA2`: Human TIGIT
|
| 40 |
-
- `TIGIT_Mouse`: Mouse TIGIT
|
| 41 |
-
|
| 42 |
-
## Citation
|
| 43 |
-
Please cite
|
| 44 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
archive/TIGIT/ym988/YM_988.csv
DELETED
|
@@ -1,3 +0,0 @@
|
|
| 1 |
-
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:bb72de2c8dac3ccfa71355289b2f7be740510022c6f64ab73dd7ef16437b6f86
|
| 3 |
-
size 35225615
|
|
|
|
|
|
|
|
|
|
|
|